How Meta could benefit from the OpenAI shakeup
Meta and Mark Zuckerberg, who had the luxury of watching the OpenAI boardroom drama from the sidelines, could end up indirectly benefiting the most. U.S. News
News from Nashville & around the world
Meta and Mark Zuckerberg, who had the luxury of watching the OpenAI boardroom drama from the sidelines, could end up indirectly benefiting the most. U.S. News
The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm. The…